References
- Leyden J J, Shalita A R. Rational therapy for acne vulgaris. J Am Acad Dermatol 1986; 15: 907–14
- Sande M A, Mandell G L. Antimicrobial agents: Tetracycline, chloramphenicol, erythromycin and miscellaneous antibacterial agents. Goodman and Gilman's The pharmacological basis of therapeutics8th edn., A G Gilman, T W Rall, A S Nies, P Taylor. Pergammon, New York 1990; 1117–25
- Leyden J J, Mc Ginley K J, Kligman A M. Tetracycline and minocycline treatment, effects on skin-surface lipid levels and Propionibacterium acnes. Arch Dermatol 1982; 118: 19–22
- Studies on file in the Clinical Research Department of Medicis Pharmaceutical Co., Phoenix
- Williamson P, Kligman A M. A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol 1965; 45: 498–503
- Barringer W C, Schultz W, Sieger G M, Nash R A. Minocycline hydrochloride and its relationship to the pharmaceutical properties of other tetracycline antibiotics. Am J Pharm 1974; 146: 179–91
- Webster G F. Inflammation in acne vulgaris. J Am Acad Dermatol 1995; 33: 247–53
- American Hospital Pharmacy Drug Information Formulary. Tetracycline General Statement 1996; 365–73
- Célérier P, Litoux P, Dréno B. In vitro modulation of epidermal inflammatory cytokines (IL-1α, IL-6, TNFα) by minocycline. Arch Dermatol Res 1996; 288: 411–14